Drug
Fosamax
Fosamax is a pharmaceutical drug with 5 clinical trials. Historical success rate of 50.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 2 completed trials
Completion Rate
50%(2/4)
Active Trials
0(0%)
Results Posted
100%(2 trials)
Terminated
2(40%)
Phase Distribution
Ph not_applicable
2
40%
Ph phase_4
1
20%
Ph phase_3
1
20%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
50.0%
2 of 4 finished
Non-Completion Rate
50.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(2)
Terminated(2)
Other(1)
Detailed Status
Completed2
Terminated2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
50.0%
Most Advanced
Phase 4
Trials by Phase
Phase 31 (25.0%)
Phase 41 (25.0%)
N/A2 (50.0%)
Trials by Status
completed240%
terminated240%
unknown120%
Recent Activity
0 active trials
Showing 5 of 5
unknownphase_4
Phase IV Clinical Trial to Evaluate Efficacy and Safety of MASI BONE S (Alendronate Sodium Trihydrate) in Postmenopausal Women With Osteoporosis
NCT05387200
completednot_applicable
99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis
NCT02304757
terminatednot_applicable
Pilot Study of Fosamax in Spinal Cord Injury
NCT01131884
terminatedphase_3
Use of Oral Bisphosphonates in the Treatment of Osteoporosis of Non-walking Children With Cerebral Palsy
NCT00822029
completed
Fosamax Bone Loss Study: Alendronate to Prevent Bone Loss
NCT00221312
Clinical Trials (5)
Showing 5 of 5 trials
NCT05387200Phase 4
Phase IV Clinical Trial to Evaluate Efficacy and Safety of MASI BONE S (Alendronate Sodium Trihydrate) in Postmenopausal Women With Osteoporosis
NCT02304757Not Applicable
99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis
NCT01131884Not Applicable
Pilot Study of Fosamax in Spinal Cord Injury
NCT00822029Phase 3
Use of Oral Bisphosphonates in the Treatment of Osteoporosis of Non-walking Children With Cerebral Palsy
NCT00221312
Fosamax Bone Loss Study: Alendronate to Prevent Bone Loss
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5